CD4 + and CD8 + T cells are required to prevent SARS-CoV-2 persistence in the nasal compartment

SARS-CoV-2 infection induces the generation of virus-specific CD4 and CD8 effector and memory T cells. However, the contribution of T cells in controlling SARS-CoV-2 during infection is not well understood. Following infection of C57BL/6 mice, SARS-CoV-2-specific CD4 and CD8 T cells are recruited to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Science advances 2024-08, Vol.10 (34), p.eadp2636
Hauptverfasser: Kar, Meenakshi, Johnson, Katherine E E, Vanderheiden, Abigail, Elrod, Elizabeth J, Floyd, Katharine, Geerling, Elizabeth, Stone, E Taylor, Salinas, Eduardo, Banakis, Stephanie, Wang, Wei, Sathish, Shruti, Shrihari, Swathi, Davis-Gardner, Meredith E, Kohlmeier, Jacob, Pinto, Amelia, Klein, Robyn, Grakoui, Arash, Ghedin, Elodie, Suthar, Mehul S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:SARS-CoV-2 infection induces the generation of virus-specific CD4 and CD8 effector and memory T cells. However, the contribution of T cells in controlling SARS-CoV-2 during infection is not well understood. Following infection of C57BL/6 mice, SARS-CoV-2-specific CD4 and CD8 T cells are recruited to the respiratory tract, and a vast proportion secrete the cytotoxic molecule granzyme B. Using depleting antibodies, we found that T cells within the lungs play a minimal role in viral control, and viral clearance occurs in the absence of both CD4 and CD8 T cells through 28 days postinfection. In the nasal compartment, depletion of both CD4 and CD8 T cells, but not individually, results in persistent, culturable virus replicating in the nasal epithelial layer through 28 days postinfection. Viral sequencing analysis revealed adapted mutations across the SARS-CoV-2 genome, including a large deletion in ORF6. Overall, our findings highlight the importance of T cells in controlling virus replication within the respiratory tract during SARS-CoV-2 infection.
ISSN:2375-2548
2375-2548
DOI:10.1126/sciadv.adp2636